Home > Insider Trading > Filing (0001493152-22-003302)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1260641	C James Czirr	545 Dutch Valley Road, N.e., Suite A Atlanta, GA 30324	Yes	No	Yes	No
1453356	10X Fund, L.p.	545 Dutch Valley Road, N.e., Suite A Atlanta, GA 30324	No	No	Yes	No
1457247	10X Capital Management, Llc	545 Dutch Valley Road, N.e., Suite A Atlanta, GA 30324	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-02	10,000	$2.10	6,178,940	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan.
10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.